SigDYN team awarded the ARC Fondation label for 3 years Treating pancreatic cancer with therapies targeting oncogenic PI3K signaling Among the various types of oncogenic signaling, activation of PI3K signaling is the most frequent in cancer. For over 10 years, the...
Metabolism and Cancer 2023 – Nice – France From 22th to 24th november 2023, Nice, France For more information (registration and programme), Toute l’actualité Toulouse Cancer Research Center (Oncopole) Toulouse - FR [feed_them_social cpt_id=55211] Contact...
Pin It on Pinterest
To improve your browsing experience. Cookies provide information on how the site is used: statistics such as the number of visitors, the average length of visits or the number of pages viewed. On the other hand, disabling cookies may prevent you from using certain features, such as sharing content via social networks.
You can adjust all your cookie settings by navigating the tabs on the left.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
This site uses Google Analytics to collect anonymous information such as the number of visitors to the site and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!